Critical Survey: ADM Tronics Unlimited (OTCMKTS:ADMT) and Treace Medical Concepts (NASDAQ:TMCI)

ADM Tronics Unlimited (OTCMKTS:ADMT) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Valuation and Earnings

This table compares ADM Tronics Unlimited and Treace Medical Concepts”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADM Tronics Unlimited	$3.20 million	1.67	-$120,000.00	N/A	N/A
Treace Medical Concepts	$212.69 million	0.81	-$59.00 million	($0.97)	-2.74

ADM Tronics Unlimited has higher earnings, but lower revenue than Treace Medical Concepts.

Risk & Volatility

ADM Tronics Unlimited has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.

Insider & Institutional Ownership

84.1% of Treace Medical Concepts shares are owned by institutional investors. 73.0% of ADM Tronics Unlimited shares are owned by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares ADM Tronics Unlimited and Treace Medical Concepts’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ADM Tronics Unlimited	-0.20%	-0.85%	-0.32%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

Analyst Recommendations

This is a summary of recent ratings and price targets for ADM Tronics Unlimited and Treace Medical Concepts, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADM Tronics Unlimited	0	0	0	0	0.00
Treace Medical Concepts	2	4	1	0	1.86

Treace Medical Concepts has a consensus price target of $4.77, indicating a potential upside of 79.32%. Given Treace Medical Concepts’ stronger consensus rating and higher possible upside, analysts clearly believe Treace Medical Concepts is more favorable than ADM Tronics Unlimited.

About ADM Tronics Unlimited

ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.

About Treace Medical Concepts

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.